Mundipharma to sell Nexodyn in African regions for APR
Executive Summary
Mundipharma International Corp. Ltd. licensed exclusive rights in Africa and the Levant Region to sell APR Applied Pharma Research SA’s Nexodyn wound cleanser.
Deal Industry
- Biotechnology
- Medical Devices
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice